cultivating a vibrant u.s. market for biosimilars: a conversation with fda’s scott gottlieb - part 2
Published 6 years ago • 994 plays • Length 49:32Download video MP4
Download video MP3
Similar videos
-
49:42
cultivating a vibrant u.s. market for biosimilars: a conversation with fda’s scott gottlieb - part 1
-
3:07
the promise of biosimilars
-
2:21
what are biosimilars?
-
0:31
self assembling 3d spheroid cultures
-
1:28
bc expands use of biosimilars
-
4:31
let's talk microalgae, its health potential and cultivation with dr. bar-gil
-
1:00:29
the future of the middle class - part 2
-
15:10
cracking the biosimilar code with biocon's kiran mazumdar shaw
-
1:27
bc expands use of biosimilars
-
8:08
fda guidance on biosimilars
-
1:23
biosimilars – what they are and what you need to know.
-
1:31:11
basics of biosimilars
-
23:07
what will it take to bring biosimilars to the market?
-
0:42
what payers need to know about biosimilars
-
3:45
what are biosimilars? how do they work for arthritis?
-
1:08
spotlighting amneal’s biosimilars business
-
2:13
biosimilars: what you need to know
-
12:01
building a sustainable market for biosimilars in the future
-
1:27
merck | biosimilars
-
1:25
potential cost savings of biosimilars
-
1:39
carving out space for innovation using biosimilars